Enhancing Clinical Trials in Obesity by Integrating Clinical Outcome Assessments and Digital Health Technologies, Upcoming Webinar Hosted by Xtalks

In this free webinar, gain insight into patterns in the current use of clinical outcome assessment (COA) and digital health technology (DHT) deployment in clinical trials for obesity. Attendees will learn about the regulatory factors affecting COA and DHT deployment across the drug development lifecycle. The speakers will share complementary strategies for COA and DHT selection to add context and differentiate a product on the market.

TORONTO, Sept. 22, 2025 /PRNewswire/ — The development landscape for overweight and obesity therapies is rapidly evolving, shaped by regulatory guidance and advances in how therapeutic value is measured. Increasingly, drug development is moving beyond traditional weight-loss metrics toward a more comprehensive view of patient health — one that prioritizes lived experience, functional ability and quality of life.

This webinar will explore how clinical outcome assessments (COAs) and digital health technologies (DHTs) are reshaping obesity trials. Historically, these trials have centered on weight reduction and comorbidity risk as primary endpoints. In recent years, however, patient-centered approaches have gained traction, driving the creation of 17 new COAs for obesity research in the past decade, supporting seven FDA and EMA label claims and prompting the deployment of more than 70 DHTs in pharma-sponsored studies.

Regulatory perspectives are evolving alongside these innovations. The FDA’s recent draft guidance on weight-loss therapies continues to prioritize weight reduction as a Phase III primary endpoint but also encourages secondary endpoints that reflect metabolic health and functional outcomes — areas where COAs can directly contribute to labeling claims.

An emerging insight from industry practice is that COAs and DHTs are not competing methodologies. When integrated thoughtfully, they can generate complementary evidence — pairing subjective patient-reported insights with objective, technology-enabled measures. This combined approach can strengthen the evidence base, meet validation and usability requirements and enhance trial efficiency, while also supporting market differentiation and clinical adoption.

Attendees will gain practical strategies for designing obesity trials that:

• Align with current regulatory expectations
• Leverage COAs and DHTs in combination to capture meaningful, patient-relevant outcomes
• Anticipate operational considerations that affect implementation and data quality

By the end of the session, participants will be equipped to optimize measurement strategies that address both scientific rigor and the evolving needs of patients and regulators.

Register for this webinar to learn how clinical outcome assessment can be integrated with digital technologies to advance obesity clinical trials.

Join Max Gaitán, Outcomes Researcher, ICON; Céline Desvignes-Gleizes, Outcomes Researcher, Mapi Research Trust; and Pat Koochaki, Senior Principal, ICON plc, for the live webinar on Tuesday, October 7, 2025, at 11am EDT (4pm BST/UK).

For more information or to register for this event, visit Enhancing Clinical Trials in Obesity by Integrating Clinical Outcome Assessments and Digital Health Technologies.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks, visit www.xtalks.com
For information about hosting a webinar, visit www.xtalks.com/why-host-a-webinar/

Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: vkovacevic@xtalks.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/enhancing-clinical-trials-in-obesity-by-integrating-clinical-outcome-assessments-and-digital-health-technologies-upcoming-webinar-hosted-by-xtalks-302562046.html

SOURCE Xtalks